Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)

• 1. 作为基质金属蛋白酶和TACE抑制剂的邻亚磺酰氨基二环杂芳基异羟肟酸的制备和用途 [P] . 中国专利： CN1138760C . 2004.02.18
• 2. 作为基质金属蛋白酶和TACE抑制剂的邻亚磺酰氨基二环杂芳基异羟肟酸的制备和用途 [P] . 中国专利： CN1280568A . 2001-01-17
• 3. Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) [P] . 美国专利： US6890915B2 . 2005-05-10

  机译： 乙内酰脲和相关杂环作为基质金属蛋白酶和/或TNF-α转换酶（TACE）的抑制剂

• 4. Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) [P] . 美国专利： US6906053B2 . 2005-06-14

  机译： 乙内酰脲和相关杂环作为基质金属蛋白酶和/或TNF-α转换酶（TACE）的抑制剂

• 5. Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) [P] . 美国专利： US7041693B2 . 2006-05-09

  机译： 乙内酰脲衍生物作为基质金属蛋白酶和/或TNF-α转化酶（TACE）的抑制剂

• 1. Correlation of Claudins6 (CLDN6) gene expression in meningioma tissue with the expression of matrix metalloproteinases (MMPs)/tissue inhibitors of matrix metalloproteinase (TIMPs) and epithelial-mesenchymal transition (EMT) genes [J] . An-Qiang Yang, Xiao-Bin Yang, Ping Li 海南医科大学学报（英文版） . 2017,第017期
• 2. Correlation of Claudins6 (CLDN6) gene expression in meningioma tissue with the expression of matrix metalloproteinases (MMPs)/tissue inhibitors of matrix metalloproteinase (TIMPs) and epithelial-mesenchymal transition (EMT) genes [J] . An-Qiang Yang, Xiao-Bin Yang, Ping Li 海南医科大学学报(英文版) . 2017,第017期
• 3. Definition of peptide inhibitors from a synthetic peptide library by targeting gelatinase B/matrix metalloproteinase-9 (MMP-9) and TNF-α converting enzyme (TACE/ADAM-17) [J] . QiuZ., YanM., LiQ., Journal of enzyme inhibition and medicinal chemistry. . 2012,第4期
• 4. Definition of peptide inhibitors from a synthetic peptide library by targeting gelatinase B/matrix metalloproteinase-9 (MMP-9) and TNF-α converting enzyme (TACE/ADAM-17) [J] . Zheng Qiu, Ming Yan, Qian Li, Journal of enzyme inhibition and medicinal chemistry. . 2012,第4期
• 5. Definition of peptide inhibitors from a synthetic peptide library by targeting gelatinase B/matrix metalloproteinase-9 (MMP-9) and TNF-α converting enzyme (TACE/ADAM-17) [J] . Zheng Qiu, Ming Yan, Qian Li, Journal of enzyme inhibition and medicinal chemistry. . 2012,第4期
• 6. Analysis of Tissue Distribution of TNF-α, TNF-α-Receptors, and the Activating TNF-α-Converting Enzyme Suggests Activation of the TNF-α System in the Aging Intervertebral Disc [C] . BEATRICE E. BACHMEIER, ANDREAS G. NERLICH, CHRISTOPH WEILER, Meeting on Cell Signaling World: Signal Transduction Pathways as Therapeutic Targets . 2007
• 7. Effect of methamphetamine on gingival fibroblast production of matrix metalloproteinase (MMP)-2 and -9 and tissue inhibitor of metalloproteinase (TIMP)-1 and -2 in vitro [D] . Farooqi, Owais Ali 2009
• 8. Comparison of the Effects of Matrix Metalloproteinase Inhibitors on TNF-α Release from Activated Microglia and TNF-α Converting Enzyme Activity [O] . Eun-Jung Lee, Pyong-Gon Moon, Moon-Chang Baek, 2014
• 9. Definition of peptide inhibitors from a synthetic peptide library by targeting gelatinase B/matrix metalloproteinase-9 (MMP-9) and TNF-α converting enzyme (TACE/ADAM-17) [O] . Qiu Zheng, Yan Ming, Liu Datao, 2012

• 1. Comparison of Properties of Tumor Necrosis Factor-α Converting Enzyme (TACE) and Some Matrix Metalloproteases (MMPs) in Catalytic Domains [J] . . 华中科技大学学报（医学）（英德文版） . 2006,第006期
• 2. Role of angiotensin converting enzyme and angiotensinogen gene polymorphisms in angiotensin converting enzyme inhibitor-mediated antiproteinuric action in type 2 diabetic nephropathy patients [J] . Neerja Aggarwal ,Pawan Kumar Kare ,Parul Varshney . 世界糖尿病杂志：英文版（电子版） . 2017,第3期
• 3. Matrix Metalloproteinases and Tissue Inhibitors of Matrix Metalloproteinases as Plasma Indicators of Bovine Cystic Ovarian Disease [J] . K. F. Hentze ,K. G. Younger ,A. R. Menino . 自然科学期刊（英文） . 2018,第8期
• 4. 血管紧张素转换酶基因多态性与原发性高血压及血管紧张素转换酶抑制剂降压作用 [C] . 曹文 ,张启高 ,陈亚利 . 第三届全国医院青年药师优秀论文学术报告会 . 1998
• 5. TNF-α转换酶(TACE)基因表达及其调控研究 [A] . 王开富 . 1999